{"entity":{"type":"insider","cik":"0001808744","url":"/insider/0001808744","json_url":"/insider/0001808744.json","name":"OrbiMed Genesis GP LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":219,"n_filings":70,"first":"2020-04-13","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Genesis GP LLC","source":"filing","n_filings":70,"first_seen":"2020-04-13","last_seen":"2026-08-11"}],"transactions":[{"id":9211160,"accession":"0000947871-26-000782","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000782","line_url":"/filing/0000947871-26-000782#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Braveheart Bio, Inc.","issuer_ticker":"BRVE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1666667.0,"shares_display":"1,666,667","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":30000006.0,"total_display":"30,000,006.00","shares_owned_after":11901826.0,"shares_owned_after_display":"11,901,826","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-11","scope":"insider"},{"id":9211159,"accession":"0000947871-26-000782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000782","line_url":"/filing/0000947871-26-000782#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Braveheart Bio, Inc.","issuer_ticker":"BRVE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":273333.0,"shares_display":"273,333","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4919994.0,"total_display":"4,919,994.00","shares_owned_after":273333.0,"shares_owned_after_display":"273,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-11","scope":"insider"},{"id":5768402,"accession":"0000947871-26-000653","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-26-000653","line_url":"/filing/0000947871-26-000653#line-4","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":787024.0,"shares_display":"787,024","price_per_share":45.38,"price_display":"45.38","price_state":"stated","total_value":35715149.12,"total_display":"35,715,149.12","shares_owned_after":6601878.0,"shares_owned_after_display":"6,601,878","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5768401,"accession":"0000947871-26-000653","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-26-000653","line_url":"/filing/0000947871-26-000653#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46776.0,"shares_display":"46,776","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":2104920.0,"total_display":"2,104,920.00","shares_owned_after":6555102.0,"shares_owned_after_display":"6,555,102","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5768400,"accession":"0000947871-26-000653","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000653","line_url":"/filing/0000947871-26-000653#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24846.0,"shares_display":"24,846","price_per_share":45.38,"price_display":"45.38","price_state":"stated","total_value":1127511.48,"total_display":"1,127,511.48","shares_owned_after":220882.0,"shares_owned_after_display":"220,882","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5768399,"accession":"0000947871-26-000653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000653","line_url":"/filing/0000947871-26-000653#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1477.0,"shares_display":"1,477","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":66465.0,"total_display":"66,465.00","shares_owned_after":219405.0,"shares_owned_after_display":"219,405","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5937343,"accession":"0000947871-26-000637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000637","line_url":"/filing/0000947871-26-000637#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272322.0,"shares_display":"272,322","price_per_share":45.02,"price_display":"45.02","price_state":"stated","total_value":12259936.44,"total_display":"12,259,936.44","shares_owned_after":7388902.0,"shares_owned_after_display":"7,388,902","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":5937340,"accession":"0000947871-26-000637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000637","line_url":"/filing/0000947871-26-000637#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9086.0,"shares_display":"9,086","price_per_share":45.02,"price_display":"45.02","price_state":"stated","total_value":409051.72,"total_display":"409,051.72","shares_owned_after":245728.0,"shares_owned_after_display":"245,728","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":6217411,"accession":"0000947871-26-000593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000593","line_url":"/filing/0000947871-26-000593#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":3502987.0,"shares_owned_after_display":"3,502,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-06-01","scope":"insider"},{"id":6217407,"accession":"0000947871-26-000593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000593","line_url":"/filing/0000947871-26-000593#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":625000.0,"shares_owned_after_display":"625,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-06-01","scope":"insider"},{"id":5761228,"accession":"0000947871-26-000461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000461","line_url":"/filing/0000947871-26-000461#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; ORBIMED CAPITAL LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1689189.0,"shares_display":"1,689,189","price_per_share":4.44,"price_display":"4.44","price_state":"stated","total_value":7499999.16,"total_display":"7,499,999.16","shares_owned_after":11808945.0,"shares_owned_after_display":"11,808,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-21","filed_date":"2026-04-23","scope":"insider"},{"id":5761227,"accession":"0000947871-26-000461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000461","line_url":"/filing/0000947871-26-000461#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; ORBIMED CAPITAL LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1126126.0,"shares_display":"1,126,126","price_per_share":4.44,"price_display":"4.44","price_state":"stated","total_value":4999999.44,"total_display":"4,999,999.44","shares_owned_after":1126126.0,"shares_owned_after_display":"1,126,126","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-21","filed_date":"2026-04-23","scope":"insider"},{"id":5901684,"accession":"0000947871-26-000421","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421#line-4","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40416.0,"shares_display":"40,416","price_per_share":6.52,"price_display":"6.52","price_state":"stated","total_value":263512.32,"total_display":"263,512.32","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-09","scope":"insider"},{"id":5901682,"accession":"0000947871-26-000421","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32523.0,"shares_display":"32,523","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":204569.67,"total_display":"204,569.67","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-09","scope":"insider"},{"id":5901680,"accession":"0000947871-26-000421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29319.0,"shares_display":"29,319","price_per_share":6.53,"price_display":"6.53","price_state":"stated","total_value":191453.07,"total_display":"191,453.07","shares_owned_after":34923.0,"shares_owned_after_display":"34,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-09","scope":"insider"},{"id":5901679,"accession":"0000947871-26-000421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":15312.0,"total_display":"15,312.00","shares_owned_after":32523.0,"shares_owned_after_display":"32,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-09","scope":"insider"},{"id":4523966,"accession":"0000947871-25-000898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000898","line_url":"/filing/0000947871-25-000898#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Capital GP V LLC; OrbiMed Israel GP II, L.P.; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500000.0,"shares_display":"3,500,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":3500000.0,"total_display":"3,500,000.00","shares_owned_after":4490254.0,"shares_owned_after_display":"4,490,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider"},{"id":4523961,"accession":"0000947871-25-000898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000898","line_url":"/filing/0000947871-25-000898#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Capital GP V LLC; OrbiMed Israel GP II, L.P.; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","shares_owned_after":9026359.0,"shares_owned_after_display":"9,026,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider"},{"id":4574627,"accession":"0000947871-25-000840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000840","line_url":"/filing/0000947871-25-000840#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP IX LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5255106.0,"shares_display":"5,255,106","price_per_share":0.8677,"price_display":"0.87","price_state":"stated","total_value":4559855.4762,"total_display":"4,559,855.48","shares_owned_after":5255106.0,"shares_owned_after_display":"5,255,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-09-02","scope":"insider"},{"id":4574616,"accession":"0000947871-25-000840","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000840","line_url":"/filing/0000947871-25-000840#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP IX LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1051021.0,"shares_display":"1,051,021","price_per_share":0.8677,"price_display":"0.87","price_state":"stated","total_value":911970.9217,"total_display":"911,970.92","shares_owned_after":1051021.0,"shares_owned_after_display":"1,051,021","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-09-02","scope":"insider"},{"id":5022638,"accession":"0000947871-25-000384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000384","line_url":"/filing/0000947871-25-000384#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3571428.0,"shares_display":"3,571,428","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":5678570.52,"total_display":"5,678,570.52","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-09","filed_date":"2025-04-11","scope":"insider"},{"id":4193178,"accession":"0000947871-25-000359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000359","line_url":"/filing/0000947871-25-000359#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":372578.0,"shares_display":"372,578","price_per_share":20.13,"price_display":"20.13","price_state":"stated","total_value":7499995.14,"total_display":"7,499,995.14","shares_owned_after":14809075.0,"shares_owned_after_display":"14,809,075","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-03","filed_date":"2025-04-04","scope":"insider"},{"id":4193174,"accession":"0000947871-25-000359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000359","line_url":"/filing/0000947871-25-000359#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":124193.0,"shares_display":"124,193","price_per_share":20.13,"price_display":"20.13","price_state":"stated","total_value":2500005.09,"total_display":"2,500,005.09","shares_owned_after":443792.0,"shares_owned_after_display":"443,792","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-03","filed_date":"2025-04-04","scope":"insider"},{"id":4453815,"accession":"0000947871-25-000345","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000345","line_url":"/filing/0000947871-25-000345#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3026.0,"shares_display":"3,026","price_per_share":54.11,"price_display":"54.11","price_state":"stated","total_value":163736.86,"total_display":"163,736.86","shares_owned_after":746171.0,"shares_owned_after_display":"746,171","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":4453810,"accession":"0000947871-25-000345","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000345","line_url":"/filing/0000947871-25-000345#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1956.0,"shares_display":"1,956","price_per_share":54.11,"price_display":"54.11","price_state":"stated","total_value":105839.16,"total_display":"105,839.16","shares_owned_after":482308.0,"shares_owned_after_display":"482,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":4453802,"accession":"0000947871-25-000345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000345","line_url":"/filing/0000947871-25-000345#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":756.0,"shares_display":"756","price_per_share":54.11,"price_display":"54.11","price_state":"stated","total_value":40907.16,"total_display":"40,907.16","shares_owned_after":186541.0,"shares_owned_after_display":"186,541","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":4453796,"accession":"0000947871-25-000333","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-9","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5279.0,"shares_display":"5,279","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":285066.0,"total_display":"285,066.00","shares_owned_after":749197.0,"shares_owned_after_display":"749,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-21","scope":"insider"},{"id":4453791,"accession":"0000947871-25-000333","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-8","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3412.0,"shares_display":"3,412","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":184248.0,"total_display":"184,248.00","shares_owned_after":484264.0,"shares_owned_after_display":"484,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-21","scope":"insider"},{"id":4453782,"accession":"0000947871-25-000333","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-7","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1320.0,"shares_display":"1,320","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":71280.0,"total_display":"71,280.00","shares_owned_after":187297.0,"shares_owned_after_display":"187,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-21","scope":"insider"},{"id":4453776,"accession":"0000947871-25-000333","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-6","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1457.0,"shares_display":"1,457","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":78692.57,"total_display":"78,692.57","shares_owned_after":754476.0,"shares_owned_after_display":"754,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":4453768,"accession":"0000947871-25-000333","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-5","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":941.0,"shares_display":"941","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":50823.41,"total_display":"50,823.41","shares_owned_after":487676.0,"shares_owned_after_display":"487,676","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":4453762,"accession":"0000947871-25-000333","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-4","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":364.0,"shares_display":"364","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":19659.64,"total_display":"19,659.64","shares_owned_after":188617.0,"shares_owned_after_display":"188,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":4453743,"accession":"0000947871-25-000333","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20911.0,"shares_display":"20,911","price_per_share":54.02,"price_display":"54.02","price_state":"stated","total_value":1129612.22,"total_display":"1,129,612.22","shares_owned_after":755933.0,"shares_owned_after_display":"755,933","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":4453735,"accession":"0000947871-25-000333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13517.0,"shares_display":"13,517","price_per_share":54.02,"price_display":"54.02","price_state":"stated","total_value":730188.34,"total_display":"730,188.34","shares_owned_after":488617.0,"shares_owned_after_display":"488,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":4453728,"accession":"0000947871-25-000333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000333","line_url":"/filing/0000947871-25-000333#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5228.0,"shares_display":"5,228","price_per_share":54.02,"price_display":"54.02","price_state":"stated","total_value":282416.56,"total_display":"282,416.56","shares_owned_after":188981.0,"shares_owned_after_display":"188,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":4699253,"accession":"0000947871-25-000308","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-15","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42930.0,"shares_display":"42,930","price_per_share":54.44,"price_display":"54.44","price_state":"stated","total_value":2337109.2,"total_display":"2,337,109.20","shares_owned_after":776844.0,"shares_owned_after_display":"776,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699248,"accession":"0000947871-25-000308","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-14","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27750.0,"shares_display":"27,750","price_per_share":54.44,"price_display":"54.44","price_state":"stated","total_value":1510710.0,"total_display":"1,510,710.00","shares_owned_after":502134.0,"shares_owned_after_display":"502,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699241,"accession":"0000947871-25-000308","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-13","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10733.0,"shares_display":"10,733","price_per_share":54.44,"price_display":"54.44","price_state":"stated","total_value":584304.52,"total_display":"584,304.52","shares_owned_after":194209.0,"shares_owned_after_display":"194,209","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699234,"accession":"0000947871-25-000308","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-12","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":933.0,"shares_display":"933","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":51361.65,"total_display":"51,361.65","shares_owned_after":819774.0,"shares_owned_after_display":"819,774","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699230,"accession":"0000947871-25-000308","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-11","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":603.0,"shares_display":"603","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":33195.15,"total_display":"33,195.15","shares_owned_after":529884.0,"shares_owned_after_display":"529,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699223,"accession":"0000947871-25-000308","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-10","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":12826.65,"total_display":"12,826.65","shares_owned_after":204942.0,"shares_owned_after_display":"204,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4699220,"accession":"0000947871-25-000308","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-9","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14267.0,"shares_display":"14,267","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":770560.67,"total_display":"770,560.67","shares_owned_after":820707.0,"shares_owned_after_display":"820,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4699213,"accession":"0000947871-25-000308","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-8","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9222.0,"shares_display":"9,222","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":498080.22,"total_display":"498,080.22","shares_owned_after":530487.0,"shares_owned_after_display":"530,487","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4699206,"accession":"0000947871-25-000308","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-7","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3567.0,"shares_display":"3,567","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":192653.67,"total_display":"192,653.67","shares_owned_after":205175.0,"shares_owned_after_display":"205,175","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4699199,"accession":"0000947871-25-000308","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-6","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106384.0,"shares_display":"106,384","price_per_share":54.29,"price_display":"54.29","price_state":"stated","total_value":5775587.36,"total_display":"5,775,587.36","shares_owned_after":835185.0,"shares_owned_after_display":"835,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699194,"accession":"0000947871-25-000308","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-5","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68766.0,"shares_display":"68,766","price_per_share":54.29,"price_display":"54.29","price_state":"stated","total_value":3733306.14,"total_display":"3,733,306.14","shares_owned_after":539845.0,"shares_owned_after_display":"539,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699189,"accession":"0000947871-25-000308","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-4","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26596.0,"shares_display":"26,596","price_per_share":54.29,"price_display":"54.29","price_state":"stated","total_value":1443896.84,"total_display":"1,443,896.84","shares_owned_after":208795.0,"shares_owned_after_display":"208,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699181,"accession":"0000947871-25-000308","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211.0,"shares_display":"211","price_per_share":55.01,"price_display":"55.01","price_state":"stated","total_value":11607.11,"total_display":"11,607.11","shares_owned_after":834974.0,"shares_owned_after_display":"834,974","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699174,"accession":"0000947871-25-000308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":55.01,"price_display":"55.01","price_state":"stated","total_value":7481.36,"total_display":"7,481.36","shares_owned_after":539709.0,"shares_owned_after_display":"539,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4699168,"accession":"0000947871-25-000308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000308","line_url":"/filing/0000947871-25-000308#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53.0,"shares_display":"53","price_per_share":55.01,"price_display":"55.01","price_state":"stated","total_value":2915.53,"total_display":"2,915.53","shares_owned_after":208742.0,"shares_owned_after_display":"208,742","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"}],"next_cursor":"2025-03-10|4699168","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002131524","name":"Braveheart Bio, Inc.","url":"/issuer/0002131524","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2026-08-11","last_seen":"2026-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2024-05-20","last_seen":"2026-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Q32 Bio Inc.","url":"/issuer/0001661998","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2026-06-01","last_seen":"2026-06-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001678660","name":"Prelude Therapeutics Inc","url":"/issuer/0001678660","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2026-04-23","last_seen":"2026-04-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001720580","name":"Adicet Bio, Inc.","url":"/issuer/0001720580","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2023-06-29","last_seen":"2026-04-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001680367","name":"Shattuck Labs, Inc.","url":"/issuer/0001680367","role":"Director","n_filings":1,"first_seen":"2025-09-02","last_seen":"2025-09-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001738021","name":"Compass Therapeutics, Inc.","url":"/issuer/0001738021","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2021-11-08","last_seen":"2025-04-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2021-03-31","last_seen":"2025-04-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001816736","name":"Disc Medicine, Inc.","url":"/issuer/0001816736","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2023-02-17","last_seen":"2025-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001776111","name":"MBX Biosciences, Inc.","url":"/issuer/0001776111","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2024-09-17","last_seen":"2025-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001604950","name":"scPharmaceuticals Inc.","url":"/issuer/0001604950","role":"Ten percent owner","n_filings":3,"first_seen":"2020-05-26","last_seen":"2024-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001664710","name":"Keros Therapeutics, Inc.","url":"/issuer/0001664710","role":"Director","n_filings":2,"first_seen":"2020-04-13","last_seen":"2024-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001831363","name":"Terns Pharmaceuticals, Inc.","url":"/issuer/0001831363","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2022-08-18","last_seen":"2024-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"ALPINE IMMUNE SCIENCES, INC.","url":"/issuer/0001626199","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2021-09-21","last_seen":"2023-12-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2020-09-29","last_seen":"2023-11-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001800315","name":"Galecto, Inc.","url":"/issuer/0001800315","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2020-11-04","last_seen":"2023-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001745020","name":"Theseus Pharmaceuticals, Inc.","url":"/issuer/0001745020","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2021-10-14","last_seen":"2023-07-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001797768","name":"Kinnate Biopharma Inc.","url":"/issuer/0001797768","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2022-02-15","last_seen":"2023-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001835579","name":"Ikena Oncology, Inc.","url":"/issuer/0001835579","role":"Director","n_filings":3,"first_seen":"2021-04-01","last_seen":"2022-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001817713","name":"Janux Therapeutics, Inc.","url":"/issuer/0001817713","role":"Director","n_filings":4,"first_seen":"2021-06-16","last_seen":"2021-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001656536","name":"Decibel Therapeutics, Inc.","url":"/issuer/0001656536","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2021-02-19","last_seen":"2021-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001664106","name":"LogicBio Therapeutics, Inc.","url":"/issuer/0001664106","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2020-10-05","last_seen":"2020-10-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808744","retrieved_at":"2026-08-21T00:50:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}